The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components?
MetadataShow full item record
© 2015 Elsevier Masson SAS. Aims: The metabolic syndrome (MetS) is a risk factor for cancer. However, it is not known if the MetS confers a greater cancer risk than the sum of its individual components, which components drive the association, or if the MetS predicts future cancer risk. Materials and methods: We linked 20,648 participants from the Australian and New Zealand Diabetes and Cancer Collaboration with complete data on the MetS to national cancer registries and used Cox proportional hazards models to estimate associations of the MetS, the number of positive MetS components, and each of the five MetS components separately with the risk for overall, colorectal, prostate and breast cancer. Hazard ratios (HR) and 95% confidence intervals (95%CI) are reported. We assessed predictive ability of the MetS using Harrell's c-statistic. Results: The MetS was inversely associated with prostate cancer (HR 0.85; 95% CI 0.72-0.99). We found no evidence of an association between the MetS overall, colorectal and breast cancers. For those with five positive MetS components the HR was 1.12 (1.02-1.48) and 2.07 (1.26-3.39) for overall, and colorectal cancer, respectively, compared with those with zero positive MetS components. Greater waist circumference (WC) (1.38; 1.13-1.70) and elevated blood pressure (1.29; 1.01-1.64) were associated with colorectal cancer. Elevated WC and triglycerides were (inversely) associated with prostate cancer. MetS models were only poor to moderate discriminators for all cancer outcomes. Conclusions: We show that the MetS is (inversely) associated with prostate cancer, but is not associated with overall, colorectal or breast cancer. Although, persons with five positive components of the MetS are at a 1.2 and 2.1 increased risk for overall and colorectal cancer, respectively, and these associations appear to be driven, largely, by elevated WC and BP. We also demonstrate that the MetS is only a moderate discriminator of cancer risk.
Showing items related by title, author, creator and subject.
Comparison of anthropometric measures as predictors of cancer incidence: A pooled collaborative analysis of 11 Australian cohortsHarding, J.; Shaw, J.; Anstey, K.; Adams, R.; Balkau, B.; Brennan-Olsen, S.; Briffa, T.; Davis, T.; Davis, W.; Dobson, A.; Flicker, L.; Giles, G.; Grant, J.; Huxley, R.; Knuiman, M.; Luszcz, M.; MacInnis, R.; Mitchell, P.; Pasco, J.; Reid, Christopher; Simmons, D.; Simons, L.; Tonkin, A.; Woodward, M.; Peeters, A.; Magliano, D. (2015)Obesity is a risk factor for cancer. However, it is not known if general adiposity, as measured by body mass index (BMI) or central adiposity [e.g., waist circumference (WC)] have stronger associations with cancer, or ...
Higher thyrotropin concentration is associated with increased incidence of colorectal cancer in older menChan, Y.; Alfonso, Helman; Chubb, S.; Fegan, P.; Hankey, G.; Golledge, J.; Flicker, L.; Yeap, B. (2016)© 2016 John Wiley & Sons Ltd.Context: Thyroid hormones regulate cellular survival and metabolism; however, their association with cancer incidence and death has not been well explored. Objectives: Our aim was to examine ...
Chan, Y.; Alfonso, Helman; Chubb, S.; Handelsman, D.; Fegan, P.; Hankey, G.; Golledge, J.; Flicker, L.; Yeap, B. (2017)Â© 2017, Springer Science+Business Media New York. Advancing age is associated with increased cancer incidence, but the role of sex hormones as risk predictors for common cancers in older men remains uncertain. This study ...